SPONSOR
ITM Solucin GmbH
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Somatostatin Receptor PositiveNETsLymphomaSolid TumorCNS TumorsRhabdomyosarcomaPeripheral Primitive Neuroectodermal TumorGIST
ITM Solucin GmbH is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Somatostatin Receptor Positive, NETs, Lymphoma, Solid Tumor.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — ITM Solucin GmbH
How many clinical trials has ITM Solucin GmbH sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by ITM Solucin GmbH, of which 1 are actively recruiting participants. These trials cover conditions including Somatostatin Receptor Positive, NETs, Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does ITM Solucin GmbH research focus on?
ITM Solucin GmbH clinical trials span Somatostatin Receptor Positive, NETs, Lymphoma, Solid Tumor, CNS Tumors, and additional conditions. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a ITM Solucin GmbH clinical trial?
To participate in a ITM Solucin GmbH trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all ITM Solucin GmbH trials with current recruitment status updated daily.
Clinical Trials by ITM Solucin GmbH
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology